Innovus Pharma Expands Its Men's Health Franchise with the Addition of Exclusive Rights to Androferti to Support Overall Male Reproductive Health and Sperm Quality for the U.S. and Canadian Market
Innovus Pharmaceuticals, Inc. ("Innovus Pharma") (OTCQB: INNV), an emerging commercial stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men and women's health and vitality, announced today that it entered into an exclusive distribution agreement with Laboratorios Q Pharma (Spain) to distribute and commercialize Androferti®, a patented and clinically proven product to support male reproductive health and sperm quality, in the U.S. and Canada.
View full press release